Insight

New study suggests significant overdiagnosis of prostate cancer in Europe – IARC

Photo taken from IARC/LinkedIn

Sep 9, 2024, 14:40

New study suggests significant overdiagnosis of prostate cancer in Europe – IARC

IARC – International Agency for Research on Cancer shared the following on LinkedIn:

“A new study, published today in The BMJ, suggests significant overdiagnosis of prostate cancer in Europe due to highly variable patterns of opportunistic testing with a blood test that measures the amount of prostate-specific antigen (PSA).”

Prostate cancer incidence and mortality in Europe and implications for screening activities: population based study

Authors: Salvatore Vaccarella, Mengmeng Li, Freddie Bray, Rune Kvale, Diego Serraino, Valentina Lorenzoni, Anssi Auvinen, Luigino Dal Maso

New study suggests significant overdiagnosis of prostate cancer in Europe - IARC

Source: IARC – International Agency for Research on Cancer/LinkedIn

Anssi Auvinen cancer Diego Serraino europe Freddie Bray IARC International Agency for Research on Cancer Luigino Dal Maso Mengmeng Li OncoDaily Oncology overdiagnosis prostate cancer PSA testing Rune Kvale Salvatore Vaccarella Valentina Lorenzoni

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage